Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Selection of hepatitis B virus (HBV) vaccine escape mutants in HBV-infected and HBV/HIV-coinfected patients failing antiretroviral drugs with anti-HBV activity.

Journal of acquired immune deficiency syndromes (1999) - 1 Nov 2007

Sheldon Julie, Ramos Belen, Garcia-Samaniego Javier, Rios Pilar, Bartholomeusz Angeline, Romero Miriam, Locarnini Stephen, Zoulim Fabien, Soriano Vincent

Abstract excerpt

BACKGROUND: Given the overlap between envelope and polymerase in the hepatitis B virus (HBV) genome, changes in antigenic sites of the HBV surface antigen may occur as a result of selection of drug-resistance mutations. METHODS: Serum HBV-DNA was isolated from 71 patients with chronic hepatitis B...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to DNA, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to Hepatitis B, Chronic

Share to Hepatitis B Vaccines

Share to Hepatitis B virus

Share to HIV Infections

Share to Treatment Failure

Source

Identifiers

PMID: 18167643
DOI: 10.1097/qai.0b013e318154bd89

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18167643-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Selection of hepatitis B virus (HBV) vaccine escape mutants in HBV-infected and HBV/HIV-coinfected patients failing antiretroviral drugs with anti-HBV activity.PMID 18167643Read ↗

Selection of a multiple drug-resistant hepatitis B virus strain in a liver-transplanted patient.Semantic proximity Read ↗

Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy.Semantic proximity Read ↗

Hepatitis B virus escape mutants induced by antiviral therapy.Semantic proximity Read ↗

Prevalence and characterization of lamivudine-resistant hepatitis B virus mutations in HIV-HBV co-infected individuals.Semantic proximity Read ↗

Virology and clinical sequelae of long-term antiviral therapy in a North American cohort of hepatitis B virus (HBV)/human immunodeficiency virus type 1 (HIV-1) co-infected patients.Semantic proximity Read ↗

Hepatitis B virus variants in an HIV-HBV co-infected patient at different periods of antiretroviral treatment with and without lamivudine.Semantic proximity Read ↗

High incidence of treatment-induced and vaccine-escape hepatitis B virus mutants among human immunodeficiency virus/hepatitis B-infected patients.Semantic proximity Read ↗

Molecular genesis of drug-resistant and vaccine-escape HBV mutants.Semantic proximity Read ↗

Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir.Semantic proximity Read ↗

Virology and clinical sequelae of drug-resistant HBV in HIV-HBV-coinfected patients on highly active antiretroviral therapy.Semantic proximity Read ↗

Antiviral resistance mutations potentiate hepatitis B virus immune evasion through disruption of its surface antigen a determinant.Semantic proximity Read ↗

Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.